La Roche-Posay
La Roche-Posay Cicaplast Baume B5+
Low risk75/100
La Roche-Posay
Hydraphase Intense Eyes
Eye Moisturizers
No higher-risk flags in the assessed ingredients. This is a screening result, not a guarantee of pregnancy safety.
16 of 16 ingredients rated
Is it suitable during pregnancy?
MamaSkin rates the recorded formula for La Roche-Posay Hydraphase Intense Eyes as No known risks (99/100). This screening result is not a guarantee of safety for every pregnancy.
Why this rating?
No higher-risk ingredient flags are shown in the assessed entries. Ingredients without a matched rating are marked Not assessed, not No known risks.
16 of 16 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
How we assess productsIngredient breakdown
The recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.
Ingredient ratings and evidence
Higher-risk flags first. Open an ingredient for evidence.
Water
No known risks
Water (Aqua) is the standard purified water used as a cosmetic solvent. It has no pregnancy-specific risk in normal topical use.
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Water, https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database/cosing-glossary-ingredients_en
Glycerin
No known risks
Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
Carbomer
No known risks
Polymer thickener used to create gel textures. Large-molecule ingredient with negligible systemic absorption.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Glycine Soja Protein
No known risks
glycine soja protein is an amino-acid, peptide, protein or related conditioning ingredient. Relevant cosmetic-family assessments support topical use, and expected systemic exposure is low. No pregnancy-specific concern was identified for normal intact-skin use; residual allergenic proteins and manufacturing quality remain relevant.
Sources: CIR Safety Assessment of Animal- and Plant-Derived Amino Acids and Hydrolyzed Proteins https://cir-safety.org/panelbook/safety-assessment-animal-and-plant-derived-amino-acids-and-hydrolyzed-proteins-used-cosmet; European Commission CosIng ingredient inventory.
Caffeine
No known risks
Methylxanthine used in cosmetics (e.g., de-puffing/firming and antioxidant support). No pregnancy-specific contraindications are identified for topical cosmetic use.
Sources: CIR (Methylxanthines); PubMed (NLM)
Show all 16 ingredients
Isohexadecane
No known risks
Low-viscosity isoparaffin emollient used for slip and lightweight texture. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Isoparaffins as Used in Cosmetics / CIR Quick Reference Table (Isohexadecane); EU CosIng / cosmetics regulatory inventory
Sodium Cocoyl Glutamate
No known risks
A mild amino-acid-derived cleansing surfactant. Cosmetic safety reviewers concluded that amino acid alkyl amides, including sodium cocoyl glutamate, are safe in current practices when formulated to be non-irritating. No pregnancy-specific concern was identified for normal use of a finished cosmetic.
Sources: CIR: Safety Assessment of Amino Acid Alkyl Amides as Used in Cosmetics https://www.cir-safety.org/sites/default/files/alkyl_amides_0.pdf
Sodium Hyaluronate
No known risks
Sodium hyaluronate (hyaluronic acid salt) is used for hydration and cushioning, with very low systemic absorption from topical use and no known pregnancy or breastfeeding concerns at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Sodium Hydroxide
No known risks
pH adjuster used in very small quantities to balance formulations. Not associated with pregnancy-specific concerns.
Sources: Scientific Committee on Consumer Safety (EU); European cosmetics regulatory framework
Disodium EDTA
No known risks
Disodium EDTA is a chelating agent used to improve formula stability and performance; it is considered low concern in topical cosmetic use, with no known pregnancy or breastfeeding risks at typical concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Hydrolyzed Hyaluronic Acid
No known risks
Humectant and skin-conditioning ingredient in the hyaluronate family. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.
Sources: CIR: Safety Assessment of Hyaluronates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Caprylyl Glycol
No known risks
Humectant and preservative booster used to support product stability. Low systemic exposure expected from topical cosmetic use.
Sources: Scientific Committee on Consumer Safety (EU); Cosmetic Ingredient Review (US)
Polysorbate 80
No known risks
Nonionic emulsifier and solubilizer used to disperse oils in cosmetic formulas. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified.
Sources: CIR: Safety Assessment of Polysorbates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Acrylamide/Sodium Acryloyldimethyltaurate Copolymer
No known risks
A high-molecular-weight polymer used to thicken and stabilise formulas. Cosmetic safety reviewers concluded that acryloyldimethyltaurate polymers are safe in current practices. Residual monomers should be controlled during manufacture.
Sources: CIR: Acryloyldimethyltaurate Polymers final assessment, April 2017; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf
Potassium Sorbate
No known risks
Preservative widely used in foods and cosmetics. Considered safe at regulated concentrations with low systemic exposure from topical use.
Sources: Scientific Committee on Consumer Safety (EU); European cosmetics regulatory framework
Sodium Benzoate
No known risks
Preservative widely used in foods and cosmetics. Considered safe at regulated concentrations with low systemic exposure from topical use.
Sources: Scientific Committee on Consumer Safety (EU); European cosmetics regulatory framework
Full recorded ingredient list
Water, Glycerin, Carbomer, Glycine Soja Protein, Caffeine, Isohexadecane, Sodium Cocoyl Glutamate, Sodium Hyaluronate, Sodium Hydroxide, Disodium EDTA, Hydrolyzed Hyaluronic Acid, Caprylyl Glycol, Polysorbate 80, Acrylamide/Sodium Acryloyldimethyltaurate Copolymer, Potassium Sorbate, Sodium Benzoate
Ingredient ratings refreshed 1 October 2026. Formulas vary by market and can change. Always compare with your packaging.
Questions about this assessment
Why does La Roche-Posay Hydraphase Intense Eyes have a No known risks rating?
No higher-risk ingredient flags are shown in the assessed entries. Ingredients without a matched rating are marked Not assessed, not No known risks. The product score is a stored assessment, not a clinical safety guarantee.
Has every ingredient in La Roche-Posay Hydraphase Intense Eyes been assessed?
16 of 16 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
Does this assessment apply to my La Roche-Posay Hydraphase Intense Eyes?
Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.
Does this pregnancy assessment also establish breastfeeding suitability?
No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.
